PAMU
SGYP

Pictet Asset Management (UK)’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Pictet Asset Management (UK)’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,107,484
Closed -$6.93M – 915
2017
Q4 		$6.93M Buy
3,107,484
+495,948
+19% +$1.23M 0.02% 589
2017
Q3 		$7.57M Buy
2,611,536
+615,025
+31% +$2.1M 0.02% 544
2017
Q2 		$7.01M Buy
1,996,511
+175,834
+10% +$725K 0.02% 545
2017
Q1 		$8.48M Buy
+1,820,677
New +$10.6M 0.03% 496

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Pictet Asset Management (UK)'s SGYP Position: Q1 2018 in Review

Pictet Asset Management (UK) sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 3,107,484 shares — an estimated $6.93M sold.

Pictet Asset Management (UK) first reported a position in SGYP in Q1 2017 and held it in 4 quarters. The position peaked at $8.48M in Q1 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

  • Pictet Asset Management (UK) reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 3,107,484 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $6.93M.
  • Pictet Asset Management (UK) first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2017 and held it in 4 quarters.
  • Pictet Asset Management (UK)'s Synergy Pharmaceuticals, Inc Common Stock position peaked at $8.48M in Q1 2017.
  • 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2018, filed 25 Apr 2018.